Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVID-19 oral vaccine (PlantPharm BioMed)
- Development stage
- Preclinical
- Lead developer
- PlantPharm BioMed
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
PlantPharm BioMed's COVID-19 oral vaccine is a plant-based, oral solid dose vaccine candidate currently in preclinical development. The vaccine is produced using a proprietary platform that expresses SARS-CoV-2 antigens within plant cells. Upon oral administration, the plant-derived antigens are delivered to the gastrointestinal tract to stimulate mucosal and systemic immunity. This delivery method is designed to provide a stable, cold-chain independent, and needle-free alternative to conventional injectable vaccines, potentially simplifying global distribution and administration.
- Other names
- COVID-19 Human VaccineCOVID19 Human VaccineCOVID 19 Human Vaccineoral solid dose COVID-19 vaccine (plant-based)COVID-19 oral vaccineCOVID19 oral vaccineCOVID 19 oral vaccine
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on COVID-19 oral vaccine (PlantPharm BioMed).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVID-19 oral vaccine (PlantPharm BioMed).